Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Favorable phase III results reported for Cytolex

March 19, 1997

Natural squalene synthase inhibitors discovered by Pfizer

March 19, 1997

Pharmacokinetics and safety of BMS-180680

March 18, 1997

Roche prepares new antiviral agents

March 18, 1997

MRC, Sankyo and Oncogene Science to develop new antiflu drugs

March 14, 1997

Sequus seeks FDA approval for new indication of Amphotec

March 14, 1997

Clinical trial results for Neuprex in hepatectomy and meningococcemia

March 13, 1997

Long-acting injectable antifungal enters phase II trials

March 13, 1997

Antiherpesvirus agent from Roche

March 13, 1997

Antifungal agents from Nihon Nohyaku

March 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...